Microarray technology as a universal tool for high-throughput analysis of biological systems.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 16787150)

Published in Comb Chem High Throughput Screen on June 01, 2006

Authors

Jens Sobek1, Kerstin Bartscherer, Anette Jacob, Jvrg D Hoheisel, Philipp Angenendt

Author Affiliations

1: Functional Genome Center Zurich, ETH Zurich/ University of Zurich, Winterhurerstrasse 190, CH- Zurich, Switzerland.

Articles by these authors

An integrated genomic analysis of human glioblastoma multiforme. Science (2008) 51.36

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science (2008) 36.02

Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science (2009) 5.31

Active Wnt proteins are secreted on exosomes. Nat Cell Biol (2012) 2.81

Cell cycle control of wnt receptor activation. Dev Cell (2009) 2.52

Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood. Clin Cancer Res (2012) 2.07

Smed-Evi/Wntless is required for beta-catenin-dependent and -independent processes during planarian regeneration. Development (2009) 1.73

The head-regeneration transcriptome of the planarian Schmidtea mediterranea. Genome Biol (2011) 1.41

Antibody microarrays: an evaluation of production parameters. Proteomics (2003) 1.28

Dual-color proteomic profiling of complex samples with a microarray of 810 cancer-related antibodies. Mol Cell Proteomics (2010) 1.21

Wnt/Frizzled signaling requires dPRR, the Drosophila homolog of the prorenin receptor. Curr Biol (2010) 1.11

The planarian flatworm: an in vivo model for stem cell biology and nervous system regeneration. Dis Model Mech (2010) 1.09

Protein and antibody microarray technology. J Chromatogr B Analyt Technol Biomed Life Sci (2003) 1.08

A Pitx transcription factor controls the establishment and maintenance of the serotonergic lineage in planarians. Development (2013) 1.01

Bacterial protein microarrays for identification of new potential diagnostic markers for Neisseria meningitidis infections. Proteomics (2005) 1.01

Smed454 dataset: unravelling the transcriptome of Schmidtea mediterranea. BMC Genomics (2010) 1.01

Multiplex approaches in protein microarray technology. Expert Rev Proteomics (2005) 0.97

Parkinson-related LRRK2 mutation R1441C/G/H impairs PKA phosphorylation of LRRK2 and disrupts its interaction with 14-3-3. Proc Natl Acad Sci U S A (2013) 0.96

Detection of tumor DNA at the margins of colorectal cancer liver metastasis. Clin Cancer Res (2011) 0.93

PNA microarrays for hybridisation of unlabelled DNA samples. Nucleic Acids Res (2003) 0.93

Comparative genome-wide analysis of small RNAs of major Gram-positive pathogens: from identification to application. Microb Biotechnol (2010) 0.91

Utilising the left-helical conformation of L-DNA for analysing different marker types on a single universal microarray platform. Nucleic Acids Res (2006) 0.87

Recruitment and activation of RSK2 by HIV-1 Tat. PLoS One (2007) 0.85

Inhibition of Growth and Gene Expression by PNA-peptide Conjugates in Streptococcus pyogenes. Mol Ther Nucleic Acids (2013) 0.84

The Bloom's syndrome helicase (BLM) interacts physically and functionally with p12, the smallest subunit of human DNA polymerase delta. Nucleic Acids Res (2008) 0.84

COMBO-FISH enables high precision localization microscopy as a prerequisite for nanostructure analysis of genome loci. Int J Mol Sci (2010) 0.79

Robust protein profiling with complex antibody microarrays in a dual-colour mode. Methods Mol Biol (2011) 0.77

Genotypic resistance testing in HIV by arrayed primer extension. Anal Bioanal Chem (2008) 0.76

Use of complex DNA and antibody microarrays as tools in functional analyses. Comp Funct Genomics (2003) 0.75

Erratum: Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies. Oncotarget (2015) 0.75

Substrate optimization and clinical validation of reporter peptides for MS-based protease profiling in serum specimens: a new approach for diagnosis of malignant disease. Int J Oncol (2011) 0.75